Post by
bingostar on Dec 23, 2020 3:18pm
failed phase 3
I do not believe that this stock double up when management has released 2 communiqu that their clinic trials have failed and they will pursue other activities , meaning they could close the shop but they have a liitle bit of cash . naturals products for krill exist already ans its not an avenue they could exploit to get rich. GLTA